ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesK22.711

K22.711

Billable

Barrett's esophagus with high grade dysplasia

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/06/2025

Code Description

ICD-10 K22.711 is a billable code used to indicate a diagnosis of barrett's esophagus with high grade dysplasia.

Key Diagnostic Point:

Barrett's esophagus with high-grade dysplasia is a precancerous condition characterized by the abnormal transformation of the esophageal lining due to chronic gastroesophageal reflux disease (GERD). Clinically, patients may present with symptoms such as heartburn, regurgitation, and difficulty swallowing. Anatomically, Barrett's esophagus involves the lower esophagus, where the normal squamous epithelium is replaced by columnar epithelium, a process known as intestinal metaplasia. The progression from Barrett's esophagus to high-grade dysplasia indicates significant cellular abnormalities that heighten the risk of esophageal adenocarcinoma. Diagnosis typically involves endoscopy with biopsy, where pathologists assess the degree of dysplasia. High-grade dysplasia is marked by severe architectural and cytological abnormalities, necessitating careful monitoring and potential intervention, such as endoscopic mucosal resection or ablation. Regular surveillance is crucial for early detection of progression to cancer, making timely diagnosis and management essential in preventing adverse outcomes.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Diagnostic complexity: Requires endoscopic evaluation and histological assessment.
  • Treatment complexity: May involve multiple treatment modalities, including surveillance, endoscopic procedures, or surgical intervention.
  • Documentation requirements: Detailed clinical documentation is necessary to support the diagnosis and treatment plan.
  • Coding specificity: Requires precise coding to differentiate between dysplasia grades and related conditions.

Audit Risk Factors

  • Common coding errors: Misclassification of dysplasia grade or failure to document the presence of dysplasia.
  • Documentation gaps: Incomplete records regarding the patient's history of GERD or surveillance findings.
  • Billing challenges: Potential denials due to lack of supporting documentation for high-grade dysplasia.

Specialty Focus

Medical Specialties

Gastroenterology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Oncology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related ICD-10 Codes

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

Barrett's esophagus with high-grade dysplasia has significant clinical implications, as it represents a critical point in the progression toward esophageal cancer. The condition affects a notable portion of the population with chronic GERD, necessitating increased surveillance and intervention strategies. Understanding the epidemiology of Barrett's esophagus can inform healthcare utilization patterns and guide quality measures aimed at reducing cancer incidence and improving patient outcomes.

ICD-9 vs ICD-10

Barrett's esophagus with high-grade dysplasia has significant clinical implications, as it represents a critical point in the progression toward esophageal cancer. The condition affects a notable portion of the population with chronic GERD, necessitating increased surveillance and intervention strategies. Understanding the epidemiology of Barrett's esophagus can inform healthcare utilization patterns and guide quality measures aimed at reducing cancer incidence and improving patient outcomes.

Reimbursement & Billing Impact

Reimbursement considerations include the need for thorough documentation of the patient's history, endoscopic findings, and biopsy results. Common denials may arise from insufficient documentation or failure to demonstrate medical necessity for procedures performed. Coders should ensure that all relevant information is included in the medical record to support the claim and reduce the risk of audits.

Resources

Clinical References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Coding & Billing References

  • •
    ICD-10 Official Guidelines for K00-K99
  • •
    Clinical Documentation Requirements

Frequently Asked Questions

What specific conditions are covered by K22.711?

K22.711 specifically covers Barrett's esophagus with high-grade dysplasia, which is characterized by severe cellular abnormalities in the esophageal lining. It is a critical condition that requires careful monitoring due to its association with an increased risk of esophageal cancer.

When should K22.711 be used instead of related codes?

K22.711 should be used when a patient has been diagnosed with Barrett's esophagus and has been confirmed to have high-grade dysplasia through biopsy. It is important to differentiate this from Barrett's esophagus without dysplasia (K22.710) or low-grade dysplasia (K22.712) for appropriate management.

What documentation supports K22.711?

Documentation for K22.711 should include endoscopic findings, biopsy results confirming high-grade dysplasia, and a comprehensive history of the patient's gastroesophageal reflux disease. Additionally, any treatment plans or follow-up recommendations should be clearly outlined.